QI
HAE icon

QV Investors’s Haemonetics HAE Stock Holding History

QV Investors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.3M Hold
30,720
– – 0.18% 63
2026
Q1 		$1.73M Buy
30,720
+8,850
+40% +$576K 0.14% 62
2025
Q4 		$1.75M Hold
21,870
– – 0.14% 60
2025
Q3 		$1.07M Buy
21,870
+7,430
+51% +$460K 0.09% 61
2025
Q2 		$1.08M Buy
14,440
+3,200
+28% +$212K 0.11% 60
2025
Q1 		$714K Buy
+11,240
New +$764K 0.07% 64

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

QV Investors's HAE Position: Q2 2026 in Review

QV Investors held its Haemonetics (HAE) position steady in Q2 2026 at 30,720 shares worth $2.3M. The position accounts for 0.18% of the portfolio, ranked #63.

QV Investors first reported a position in HAE in Q1 2025 and has held it in 6 quarters since. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • QV Investors held 30,720 shares of Haemonetics worth $2.3M as of Q2 2026.
  • QV Investors left its Haemonetics share count unchanged in Q2 2026.
  • Haemonetics made up 0.18% of QV Investors's portfolio in Q2 2026, its #63 holding.
  • QV Investors first reported a position in Haemonetics in Q1 2025 and has held it in 6 quarters since.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on QV Investors's 13F filing for Q2 2026, filed 21 Jul 2026.